Jay S. Markowitz

Senior Vice President, Portfolio Management at Regeneron Pharmaceuticals, Inc.

Jay S. Markowitz

Jay S. Markowitz

Senior Vice President, Portfolio Management at Regeneron Pharmaceuticals, Inc.

Overview
RelSci Relationships

882

Contact Data
Trying to get in touch with Jay S. Markowitz? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Jay S. Markowitz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder, President & Chief Executive Officer at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Founding Scientist at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Director, Clinical Sciences at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Director, Public Policy at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Financial Officer & Executive Vice President-Finance at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Secretary, Executive Vice President & General Counsel at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Executive Vice President & General Manager, Industrial Operations & Product Supply at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Chief Accounting Officer, Vice President & Controller at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Vice President, Head, Regeneron Genetics Center at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Senior Director Clinical Finance at Regeneron Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Jay S. Markowitz
Potential Connections via
Relationship Science
You
Jay S. Markowitz
Senior Vice President, Portfolio Management at Regeneron Pharmaceuticals, Inc.
Education

Columbia University is one of the world's most important centers of research and at the same time a distinctive and distinguished learning environment for undergraduates and graduate students in many scholarly and professional fields. The University recognizes the importance of its location in New York City and seeks to link its research and teaching to the vast resources of a great metropolis. It seeks to attract a diverse and international faculty and student body, to support research and teaching on global issues, and to create academic relationships with many countries and regions. It expects all areas of the university to advance knowledge and learning at the highest level and to convey the products of its efforts to the world.

MD

Duke Medicine conceptually integrates the Duke University Health System, the Duke University School of Medicine, and the Duke University School of Nursing. It is the combination of research, clinical care, and education that takes place through the efforts of our faculty, staff, students, and trainees at many different sites throughout our region and worldwide. In 2006, Duke Medicine adopted new mission and vision statements that describe the overarching goals and shared aspirations of all of its components -- including the Duke University Health System, the Duke University School of Medicine, and the Duke University School of Nursing. We also finalized strategic plans to guide our efforts over the next five to 10 years.

Career History
Vice President
Prior

Price Associates' investment approach is based on the belief that fundamental proprietary research drives value-added, active investment management. The firm maintains a global research platform that includes interconnected teams of research analysts. Their strategy begins with bottom-up analysis. Price Associates uses both qualitative and quantitative analysis to evaluate investment opportunities. Portfolios are created with a commitment to diversification and a strict attention to valuation appropriate to the chosen investment universe. The firm focuses its analytical process on three areas of research: the industry, the contracts issued, and the creditworthiness of each individual issuer. Price Associates' Private Asset management Group provides balanced, equity and fixed-income investment management services to meet the needs of individuals, trusts, endowments, foundations, institutions, retirement plans and IRAs and other entities.

Investment Analyst
2010 - Current

CR&M maintains an investment philosophy that is distinguished by four key beliefs: solid research is fundamental to sound investment decisions; investment decisions should not be made lightly; a long-term approach; and the Capital System. The firm's investment decisions are subject to a fund's or account's objectives, policies and restrictions and the oversight of the appropriate investment-related committees of the firm and its investment divisions. They generally invest in equity securities, fixed-income securities or a combination of both and in U.S. and international equity securities, including common stocks, preferred stocks and convertible securities, of companies with varying market capitalizations. CR&M typically builds portfolios for funds and accounts from the bottom-up using rigorous fundamental research to find attractive investments and manage risks.

Senior Vice President, Portfolio Management
2017 - Current

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Political Donations
$1,000
2008

Former President of United States

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Jay S. Markowitz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Jay S. Markowitz's profile does not indicate a business or promotional relationship of any kind between RelSci and Jay S. Markowitz.